Biologos, a life sciences manufacturer and portfolio company of private investor Ampersand Capital Partners, has appointed Hetal Patel as chief executive officer as the company enters its next phase of expansion under private equity ownership.
Activist hedge fund Irenic Capital Management has hired former Apollo Global Management principal E‑Fei Wang as managing director and head of private equity as the firm expands beyond public market activism, according to a report by Bloomberg.
Advent International is reportedly considering the sale of its naval defence business, Ultra Maritime, in a deal that could value the unit at around $4bn, according to a report by Bloomberg citing unnamed sources familiar with the matter.
EQT is exploring options for the sale of enterprise software company SUSE in a transaction that could value the business at as much as $6bn, according to a report by Bloomberg citing unnamed people familiar with the matter.
Oak Hill Capital has agreed to acquire garage door repair and replacement business Guild Garage Group, in a deal valued at more than $800m, according to a report by Reuters citing people familiar with the matter.
New Mountain Capital has ended discussions over a proposed transaction led by former executive Matt Holt to acquire five of the firm’s portfolio companies, scrapping what would have been a deal valued at about $32bn, according to a report by Bloomberg.
Blue Owl Capital has led a $750m private credit financing to support Vista Equity Partners’ acquisition of employee management software business Nexthink, according to a report by Bloomberg.
BlackRock has limited withdrawals from its $26bn HPS Corporate Lending Fund after an increase in redemption requests, according to a report by Bloomberg.
Private investment major KKR is exploring a potential multibillion-dollar sale of data centre cooling provider CoolIT Systems, aiming to capitalise on surging demand for artificial intelligence infrastructure, according to a report by the Financial Times.
Private equity firm Lone Star Funds has agreed to acquire the capsules and health ingredients division of Swiss life sciences group Lonza in a transaction valuing the business at CHF2.3bn (around $3bn), according to a report by Reuters.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
